The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression
Clinical trial NCT00035321 · COMPLETED
Trial details
- NCT number
- NCT00035321
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-04-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.